clinical trial · NCT07278349
Bioequivalence Study to Compare Vonoprazan 20 mg Film Coated Tablets Versus Voquezna® 20 mg (Vonoprazan) Tablets
Humanis Saglık Anonim Sirketi·phase1·completed·n = 28
Erosive GastritisErosive Esophagitis(EE)HELICOBACTER PYLORI INFECTIONSVonoprazan TabletsVOQUEZNA® Tablets
brief summary
Randomized, Single Dose, Two-Way Crossover, Open Label bioequivalence study to compare Vonoprazan 20 mg Film Coated Tablets versus Voquezna® 20 mg (Vonoprazan) Tablets an oral administration to healthy adults under fasting conditions
started
Sep 21, 2025
primary completion
Oct 4, 2025
completion
Dec 9, 2025
last updated
Dec 12, 2025
official title
Randomized, Single Dose, Two-Way Crossover, Open Label Bioequivalence Study to Compare Vonoprazan 20 mg Film Coated Tablets Versus Voquezna® 20 mg (Vonoprazan) Tablets an Oral Administration to Healthy Adults Under Fasting Conditions
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol